ResMed Inc. (RMD) Stock Overview
Explore ResMed Inc.’s financial performance, market position, analyst ratings, and future outlook.
ResMed Inc. (RMD)
Key Financials
Key Financials
Market Cap
29.2B
P/E Ratio
19.42
EPS (TTM)
$10.77
ROE
0.24%
RMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of ResMed Inc. (RMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 54.83, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $213.94.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 19.42 and a market capitalization of 29.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.